power to detect a difference of 0.5% in the change from baseline in A1C values be-tween at least one exenatide treatmentarm and placebo (/H9251/H110050.05; Fisherâ€™s pro-tected testing procedure). Placebo arms Cand D were combined for all analyses. All inferential statistical tests were